Key Insights
- The onsemi Synaptics deal now values Synaptics at about $5.7 billion in cash, down from roughly $7 billion under the prior stock agreement.
- onsemi secured up to $2.45 billion of term-loan financing, equal to about 43% of the revised deal value.
- Synaptics closed at $121.10, only 1.5% below the $123 offer, while onsemi gained nearly 6%.
The onsemi Synaptics deal shifted to $123 per share in cash after Synaptics received an unsolicited rival proposal. The amended terms value Synaptics at about $5.7 billion, versus roughly $7 billion previously.
Friday’s market reaction favored both sides. onsemi closed at $84.89, up 5.98%, while Synaptics rose 14.10% to $121.10. Synaptics finished $1.90 below the cash offer.
What changed in the onsemi Synaptics deal
The June agreement offered 1.35 onsemi shares for each Synaptics share. The new structure removes that exchange ratio and gives Synaptics holders a fixed cash payment.
The lower headline value reflects onsemi’s share-price decline after the original announcement. Cash now removes dilution for onsemi investors but transfers more financing risk to its balance sheet.
onsemi-Synaptics deal values and financing
$2.45 billion loan changes the risk
The onsemi filing showed Morgan Stanley Senior Funding committed up to $2.45 billion. The senior secured term loan will fund part of the purchase and related expenses.
That commitment covers about 43% of the revised transaction value. Receipt of the financing is not a condition to onsemi’s obligation to close, according to the filing.
The amendment also removed several conditions tied to the former stock structure. These included an effective registration statement, Nasdaq approval for newly issued shares and closing tax opinions.
onsemi expects immediate non-GAAP earnings accretion after closing. It also identified potential benefits beyond the original $200 million annual run-rate synergy estimate, including manufacturing insourcing.
The next catalyst is the shareholder proxy
The market left a 1.5% spread between Synaptics’ close and the cash offer. That narrow gap suggests traders assign high odds to completion, although regulatory and shareholder approvals remain.
The companies said the Federal Trade Commission has approved the transaction. Reviews continue in other jurisdictions, and closing remains targeted for mid-2027.
Synaptics must file a preliminary proxy within 10 days of the Oct. 1 amendment. The shareholder meeting must follow within 30 days after the SEC clears the proxy or declines review.
The deal also expands onsemi’s position in connected computing and edge AI. Related semiconductor-stock coverage will focus next on the proxy terms, leverage disclosures and remaining regulatory approvals.
Elsy kanana
Elsy Kanana is a financial and cryptocurrency journalist at FusionMarketNews, covering digital assets, blockchain technology, financial markets, and emerging fintech trends. Her reporting focuses on market movements, regulatory developments, and on-chain analytics, delivering clear, data-driven insights to readers worldwide.
